IGF1 and hepatocellular carcinoma: Another study of patients with decompensated cirrhosis (without HCC) revealed that serum IGF-1 levels (median: 70.1, 40.5, and 32.4 ng/mL for CP class A, B, and C, respectively) and IGF-CP scores were associated with 1 year mortality (5).